Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

By sjmartinez • May 18, 2025

Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, Mendez CE, Kelley KD, Stewart E, Fernandez Robles CR, Chadha RM, Camilleri M, Mathur R, Umpierrez GE, Hepner DL. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025 May 15:S0007-0912(25)00214-4. doi: 10.1016/j.bja.2025.04.001. Epub ahead of print. PMID: 40379536.

Tags: Cedars Sinai DoM, diabetes mellitus, Endocrinology, gastric emptying, glucagon-like peptide 1 receptor agonists, major adverse cardiovascular events, Obesity, perioperative care, Publications

PRIME 2.0: An Update to The Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation Checklist

Kagiyama N, Tokodi M, Hathaway QA, Arnaout R, Davies R, Dey D, Duchateau N, Fraser AG, Goto S, Jamthikar AD, Lam CSP, Oikonomou EK, Ouyang[...]

Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial

Reuben DB, Stevens AB, Gill TM, Williamson J, Volpi E, Lichtenstein ML, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan[...]

Reply to Letter on “Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in the U.S., 2021-2040”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to Letter on "Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in[...]